🗂️ Navigation

Clinical Ink Lunexis ePRO

A better eCOA & ePRO solution that improves data collection and quality.

Visit Website →

Overview

Clinical Ink's Lunexis ePRO is part of their broader eSource platform, which aims to capture all trial data electronically at the source. The platform is designed to improve patient experience and data quality by integrating patient engagement features with a configurable ePRO module. It supports BYOD and provisioned device models and is built to handle the complexities of various therapeutic areas. Clinical Ink emphasizes its ability to provide a single platform for Direct Data Capture (DDC), eCOA, ePRO, and eConsent, reducing the need for multiple systems.

✨ Key Features

  • Part of an integrated eSource ecosystem (Lunexis)
  • Configurable point-and-click ePRO builder
  • Supports BYOD and provisioned devices
  • In-app patient training diary
  • Integrated patient engagement tools
  • Direct Data Capture (DDC) capabilities

🎯 Use Cases (4)

Patient-reported outcomes (PROs) Electronic diaries Complex clinical trials with multiple data sources Hybrid and decentralized trials

✅ Best For

  • Neuroscience (e.g., Alzheimer's, Parkinson's)
  • Immunology
  • Rare disease

💻 Platforms

iOS Android Web

✅ Offline Mode Available

🔌 Integrations

Lunexis eConsent Lunexis Direct Data Capture (DDC) Third-party EDC systems via API

🛟 Support Options

  • ✓ Email Support
  • ✓ Phone Support
  • ✓ Dedicated Support (Enterprise tier)

🔒 Compliance & Security

✓ SOC 2 ✓ HIPAA ✓ BAA Available ✓ GDPR ✓ ISO 27001 ✓ SSO ✓ ISO 27001 ✓ SOC 2 Type II ✓ GCP ✓ 21 CFR Part 11

💰 Pricing

Contact for pricing
Visit Clinical Ink Lunexis ePRO Website →